NHI National Health Investors (NHI) Insider Trading, Ownership & Congress Trades
Real Estate · Real estate investment trusts · CIK 0000877860
C-suite buying · 1Congress · 1Form 144 · 1
Funds added, last quarter
156
13F, latest reported quarter
What the filings say about NHI
Insiders, 180 days
+$167.0K net bought
2 buyers
Congress, 1 year
1 bought · 0 sold
Latest: purchase, 2026-07-10
Planned sales (Form 144), 90 days
$2.4M
1 notice
National Health Investors insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, NATIONAL HEALTH INVESTORS INC insiders bought a net $167.0K of stock across 21 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 31, 2024.
- +9.9% median (+9.9% mean) 90-day return after 2 previous buys.
- The trade is 2.0% of the 44,158 shares held after it.
- 1 other insider bought within 30 days.
- 156 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MCCABE ROBERT A JR bought about $63.8K of NHI on Jun 15, 2026; 1 other insider bought within 30 days and 156 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Sep 29, 2021.
- The trade is 1.1% of the 133,316 shares held after it.
- 1 other insider bought within 30 days.
- 156 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO and President Mendelsohn D. Eric bought about $103.3K of NHI on Jun 5, 2026, the largest insider purchase at the company since 2024; 1 other insider bought within 30 days and 156 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Sep 9, 2021.
- The trade is 2.0% of the 21,585 shares held after it.
- No other insider bought within 30 days.
- 156 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MCCABE ROBERT A JR bought about $28.8K of NHI on May 31, 2024; 156 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 9.1% of the 110,185 shares held after it.
- No other insider bought within 30 days.
- 156 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director SWAFFORD CHARLOTTE A bought about $586.9K of NHI on Feb 27, 2024, the largest insider purchase at the company on our record; 156 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 6.7% of the 14,979 shares held after it.
- No other insider bought within 30 days.
- 156 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Jobe James R bought about $51.4K of NHI on Aug 30, 2023; 156 funds added in the latest 13F quarter.21 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$167.0K over 180 days
more than 76% of Real Estate
Congress
1 member bought in the last year
the lowest in Real Estate
Funds
156 funds bought in last quarter
more than 61% of Real Estate
Revenue
+47.1% year over year
more than 92% of Real Estate
Margin
177.6% net margin
more than 91% of Real Estate
Buybacks
no share repurchases reported
Short interest
4.7% of the float short (float per yahoo 2026-10-27) · 6.6 days to cover · settled 2026-10-15
more than 56% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch NHI
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-7.2%12M
Insider buyForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns NHI: institutional holders (13F)
13F holdings, latest reported quarter
8,733,237 sh
$666.0M
4,630,646 sh
$353.1M
2,735,937 sh
$211.1M
2,099,145 sh
$160.1M
1,977,094 sh
$150.8M
Congress trades in NHI
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Bought 2026-07-10 · disclosed 56 days later
$1,001 - $15,000
Bought 2026-01-15 · disclosed 29 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
NHI planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Spaid John L
Filed 2026-08-17
$2.4M
NHI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
BNY Mellon Global Infrastructure Income ETF
$40.1M position · as of 2026-07-31
3.1%
PGIM Real Estate Income Fund
$1.2M position · as of 2026-07-31
2.0%
Global X SuperDividend U.S. ETF
$12.9M position · as of 2026-07-31
1.7%
Principal Real Estate Active Opportunities ETF
$315.3K position · as of 2026-06-30
1.2%
Nomura Small Cap Value Fund
$40.2M position · as of 2026-05-29
1.2%
Nomura VIP Small Cap Value Series
$21.7M position · as of 2026-06-30
1.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · D. Eric Mendelsohn
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.7M
$3.8M
$1.7M
+48%
+38%
2024
$2.2M
$2.7M
$1.1M
+28%
+34%
2023
$2.1M
$2.0M
$1.1M
-2%
+23%
2022
$2.7M
$1.8M
$1.1M
-15%
+8%
2021
$2.6M
$2.1M
$1.1M
-12%
+43%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $167.0K bought by insiders over 180 days, 156 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $2.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
NHI financials
Revenue growth
+47.1%
XBRL, annual
Net margin
177.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$432.1M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM NHI
| FY Dec 2025 | $375.6M |
| FY Dec 2024 | $335.2M |
| FY Dec 2023 | $319.8M |
| FY Dec 2022 | $278.2M |
| FY Dec 2021 | $298.7M |
| Jun 2026 | $121.3M |
| Mar 2026 | $115.1M |
| Dec 2025 | $105.8M |
| Sep 2025 | $89.8M |
| Jun 2025 | $90.7M |
| Mar 2025 | $89.3M |
| Dec 2024 | $85.8M |
| Sep 2024 | $82.9M |
At each fiscal year end
Single quarter
Net margin, TTM
+38.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM NHI
| FY Dec 2025 | +37.9% |
| FY Dec 2024 | +41.2% |
| FY Dec 2023 | +42.4% |
| FY Dec 2022 | +23.9% |
| FY Dec 2021 | +37.4% |
| Jun 2026 | +45.9% |
| Mar 2026 | +34.8% |
| Dec 2025 | +36.1% |
| Sep 2025 | +36.6% |
| Jun 2025 | +40.8% |
| Mar 2025 | +38.3% |
| Dec 2024 | +50.4% |
| Sep 2024 | +34.4% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | -$52.7M |
| FY Dec 2022 | -$51.8M |
| FY Dec 2021 | -$26.3M |
| Jun 2026 | n/a |
| Mar 2026 | -$56.0M |
| Dec 2025 | -$75.6M |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | -$38.7M |
| Dec 2024 | -$53.3M |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity NHI
| FY Dec 2025 | +9.8% |
| FY Dec 2024 | +10.5% |
| FY Dec 2023 | +10.7% |
| FY Dec 2022 | +4.8% |
| FY Dec 2021 | +7.4% |
| Jun 2026 | +10.9% |
| Mar 2026 | +10.1% |
| Dec 2025 | +9.8% |
| Sep 2025 | +10.9% |
| Jun 2025 | +10.5% |
| Mar 2025 | +10.6% |
| Dec 2024 | +10.5% |
| Sep 2024 | +10.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets NHI
| FY Dec 2025 | +5.3% |
| FY Dec 2024 | +5.4% |
| FY Dec 2023 | +5.4% |
| FY Dec 2022 | +2.5% |
| FY Dec 2021 | +3.8% |
| Jun 2026 | +5.9% |
| Mar 2026 | +5.2% |
| Dec 2025 | +5.3% |
| Sep 2025 | +5.7% |
| Jun 2025 | +5.5% |
| Mar 2025 | +5.4% |
| Dec 2024 | +5.4% |
| Sep 2024 | +5.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
19.50x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing NHI
| FY Dec 2025 | 25.29x |
| FY Dec 2024 | 22.14x |
| FY Dec 2023 | 17.84x |
| FY Dec 2022 | 35.28x |
| FY Dec 2021 | 23.65x |
| Jun 2026 | 22.04x |
| Mar 2026 | 26.08x |
| Dec 2025 | 25.29x |
| Sep 2025 | 25.00x |
| Jun 2025 | 22.33x |
| Mar 2025 | 23.37x |
| Dec 2024 | 22.14x |
| Sep 2024 | 28.89x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | -2.2% |
| FY Dec 2022 | -2.3% |
| FY Dec 2021 | -1.0% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | -0.9% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.91x
P/E over trailing EPS growth of 10%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing NHI
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.16x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 2.16x |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 2.69x |
| Jun 2025 | 3.28x |
| Mar 2025 | 6.48x |
| Dec 2024 | n/a |
| Sep 2024 | 1.50x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $375.6M | $335.2M | $319.8M | $278.2M |
| Net income | $142.2M | $138.0M | $135.7M | $66.4M |
| EPS (diluted) | 3.02 | 3.13 | 3.13 | 1.48 |
| Operating cash flow | $236.6M | $207.8M | $184.4M | $185.3M |
| Cash | $19.6M | $24.3M | $22.3M | $19.3M |
| Buybacks | n/a | $0 | $0 | $152.0M |
| Dividends paid | $169.7M | $156.5M | $156.2M | $161.8M |
SEC XBRL, fiscal years, as known on 2026-10-28
NHI Stock Sonar score 5/7 axes
Find similar shapesCompareNHI ranks highest on growth (92nd percentile) and profitability (85th), and lowest on risk and compliance (32nd), among Real Estate peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NHI filings, in plain words
Are National Health Investors insiders buying or selling NHI?
In the 180 days to 2026-10-28, National Health Investors insiders were net buyers, a net $167.0K across purchases and sales reported on Form 4, by 2 buyers.
Have members of Congress traded NHI?
Yes. In the year to 2026-10-28, 1 House member disclosed buying NHI and 0 House members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-07-10.
Are there planned insider sales of NHI?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $2.4M of stock; the latest, by Spaid John L, was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-28, National Health Investors insiders were net buyers of NHI, a net $167.0K across purchases and sales reported on Form 4 by 2 buyers. In the year to 2026-10-28, 1 member of Congress disclosed buying NHI and 0 members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-07-10. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $2.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
